000 | 01011 a2200313 4500 | ||
---|---|---|---|
005 | 20250513014444.0 | ||
264 | 0 | _c19810820 | |
008 | 198108s 0 0 ita d | ||
022 | _a0009-9074 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPala, A | |
245 | 0 | 0 |
_a[Papaveroline in mental disorders caused by a deficit of non-focalized cerebral circulation]. _h[electronic resource] |
260 |
_bLa Clinica terapeutica _cJan 1981 |
||
300 |
_a39-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCerebrovascular Disorders _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPapaverine _xanalogs & derivatives |
650 | 0 | 4 |
_aTetrahydropapaveroline _xanalogs & derivatives |
650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
700 | 1 | _aAlleva, P M | |
773 | 0 |
_tLa Clinica terapeutica _gvol. 96 _gno. 1 _gp. 39-44 |
|
999 |
_c7237472 _d7237472 |